These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

51 related items for PubMed ID: 2841615

  • 1. [Chronic polyneuritis of the Guillain-Barré type. Significance of long-term electroneurographic follow-up findings].
    Haupt WF, Gibbels E, Hann P.
    Nervenarzt; 1988 May; 59(5):274-7. PubMed ID: 2841615
    [Abstract] [Full Text] [Related]

  • 2. [Plasma exchange treatment in chronic polyneuritis of the Guillain-Barré type. Experiences with 9 personal cases].
    Gibbels E, Toyka KV, Borberg H, Haupt WF, Hann P.
    Nervenarzt; 1986 Mar; 57(3):129-39. PubMed ID: 3960229
    [Abstract] [Full Text] [Related]

  • 3. Plasma exchange in Guillain-Barré syndrome: one-year follow-up. French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome.
    Ann Neurol; 1992 Jul; 32(1):94-7. PubMed ID: 1642477
    [Abstract] [Full Text] [Related]

  • 4. [Functional recovery in Guillain-Barre syndrome: benefits of plasma exchange].
    Cassuto-Viguier E, Sanderson F, Kullman B, Quaranta JF, Montagne N, Gueyraud A, Therre C, Duplay H.
    Ann Med Interne (Paris); 1988 Jul; 139 Suppl 1():43-5. PubMed ID: 3247991
    [Abstract] [Full Text] [Related]

  • 5. [Plasmapheresis therapy in Guillain-Barré polyneuroradiculitis].
    Zwahlen H, Quadri F, Mombelli G, Tatti V, Marone C.
    Schweiz Med Wochenschr; 1988 Dec 10; 118(49):1854-8. PubMed ID: 3217776
    [Abstract] [Full Text] [Related]

  • 6. Guillain Barre syndrome-electrodiagnostic features and therapeutic observations.
    Shankar V, Bhanu K, Sayeed ZA.
    J Assoc Physicians India; 1995 Oct 10; 43(10):670-2. PubMed ID: 8773000
    [Abstract] [Full Text] [Related]

  • 7. [The prognostic significance of electromyographic and electroneurographic results in Landry-Guillain-Barré-Strohl polyradiculoneuritis].
    Reichel G, Perlwitz R, Wagner A.
    Psychiatr Neurol Med Psychol (Leipz); 1981 May 10; 33(5):281-9. PubMed ID: 7255617
    [Abstract] [Full Text] [Related]

  • 8. Appropriate number of plasma exchanges in Guillain-Barré syndrome. The French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome.
    Ann Neurol; 1997 Mar 10; 41(3):298-306. PubMed ID: 9066350
    [Abstract] [Full Text] [Related]

  • 9. Efficiency of plasma exchange in Guillain-Barré syndrome: role of replacement fluids. French Cooperative Group on Plasma Exchange in Guillain-Barré syndrome.
    Ann Neurol; 1987 Dec 10; 22(6):753-61. PubMed ID: 2893583
    [Abstract] [Full Text] [Related]

  • 10. The acute phase reactant, fibrinogen, as a guide to plasma exchange therapy for acute Guillain-Barré syndrome.
    Sanjay R, Flanagan J, Sodano D, Gorson KC, Ropper AH, Weinstein R.
    J Clin Apher; 2006 Jul 10; 21(2):105-10. PubMed ID: 16342192
    [Abstract] [Full Text] [Related]

  • 11. Guillain-Barré syndrome treated by membrane plasma exchange and/or immunoadsorption.
    Marn Pernat A, Buturović-Ponikvar J, Svigelj V, Ponikvar R.
    Ther Apher Dial; 2009 Aug 10; 13(4):310-3. PubMed ID: 19695065
    [Abstract] [Full Text] [Related]

  • 12. Guillain-Barré syndrome in children: evidence of axonal degeneration and long-term follow-up.
    Currie DM, Nelson MR, Buck BC.
    Arch Phys Med Rehabil; 1990 Mar 10; 71(3):244-7. PubMed ID: 2317145
    [Abstract] [Full Text] [Related]

  • 13. Long-term treatment of chronic inflammatory demyelinating polyradiculoneuropathy with plasma exchange or intravenous immunoglobulin.
    Choudhary PP, Hughes RA.
    QJM; 1995 Jul 10; 88(7):493-502. PubMed ID: 7633875
    [Abstract] [Full Text] [Related]

  • 14. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.
    Hadden RD, Cornblath DR, Hughes RA, Zielasek J, Hartung HP, Toyka KV, Swan AV.
    Ann Neurol; 1998 Nov 10; 44(5):780-8. PubMed ID: 9818934
    [Abstract] [Full Text] [Related]

  • 15. [Comparative study of the efficacy of plasma exchange, immunoadsorption plasmapheresis and corticosteroid administration in the treatment of Guillain-Barré syndrome].
    Yamazaki M, Koh CS, Hanyu N, Sakai T, Inoue A, Yanagisawa N.
    Arerugi; 1995 Apr 10; 44(4):498-502. PubMed ID: 7598643
    [Abstract] [Full Text] [Related]

  • 16. Unintended plasma exchange therapy in poliomyelitis: difficulties in the differential diagnosis of paralytic poliomyelitis and polyradiculitis.
    Färkkilä M, Kinnunen E, Hovi T, Iivanainen M.
    Ann Clin Res; 1987 Apr 10; 19(6):395-8. PubMed ID: 3451693
    [Abstract] [Full Text] [Related]

  • 17. [Guillain-Barre syndrome. Current treatment principles in the light of clinical aspects].
    Gerdts R, Jensen D, Fauchald P, Skjeldal O.
    Tidsskr Nor Laegeforen; 1999 Feb 10; 119(4):506-9. PubMed ID: 10081373
    [Abstract] [Full Text] [Related]

  • 18. [Treatment of Guillain-Barré syndrome with high-dose intravenous immunoglobulins--a comparison with plasma exchange].
    Kamei T, Nakagawa H, Uchiyama F, Fukuyama J.
    Rinsho Shinkeigaku; 1993 Jun 10; 33(6):660-2. PubMed ID: 8403689
    [Abstract] [Full Text] [Related]

  • 19. Guillain-Barré syndrome after bone marrow transplantation.
    Perry A, Mehta J, Iveson T, Treleaven J, Powles R.
    Bone Marrow Transplant; 1994 Jul 10; 14(1):165-7. PubMed ID: 7951108
    [Abstract] [Full Text] [Related]

  • 20. Clinical presentation and course of childhood Guillain-Barré syndrome: a prospective multicentre study.
    Korinthenberg R, Schessl J, Kirschner J.
    Neuropediatrics; 2007 Feb 10; 38(1):10-7. PubMed ID: 17607598
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.